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Defects in translocation of the glucose transporterGLUT4are
associated with peripheral insulin resistance, preclinical diabe-
tes, and progression to type 2 diabetes. GLUT4 recruitment to
the plasma membrane of skeletal muscle cells requires F-actin
remodeling. Insulin signaling in muscle requires p21-activated
kinase-1 (PAK1), whose downstream signaling triggers actin
remodeling,whichpromotesGLUT4vesicle translocationandglu-
cose uptake into skeletal muscle cells. Actin remodeling is a cyclic
process, and although PAK1 is known to initiate changes to the
cortical actin-binding protein cofilin to stimulate the depolymer-
izing arm of the cycle, how PAK1 might trigger the polymerizing
arm of the cycle remains unresolved. Toward this, we investigated
whether PAK1 contributes to themechanisms involving the actin-
binding and -polymerizing proteins neural Wiskott-Aldrich syn-
drome protein (N-WASP), cortactin, and ARP2/3 subunits. We
found that the actin-polymerizing ARP2/3 subunit p41ARC is a
PAK1substrate inskeletalmusclecells.Moreover, co-immunopre-
cipitation experiments revealed that insulin stimulates p41ARC
phosphorylation and increases its associationwithN-WASP coor-
dinatelywith theassociationsofN-WASPwithcortactinandactin.
Importantly, all of these associations were ablated by the PAK
inhibitor IPA3, suggesting that PAK1 activation lies upstream of
these actin-polymerizing complexes.Using theN-WASP inhibitor
wiskostatin,we furtherdemonstrated thatN-WASPis required for
localized F-actin polymerization, GLUT4 vesicle translocation,
and glucose uptake. These results expand the model of insulin-
stimulated glucose uptake in skeletal muscle cells by implicating
p41ARC as a new component of the insulin-signaling cascade and
connectingPAK1 signaling toN-WASP-cortactin–mediated actin
polymerization andGLUT4 vesicle translocation.
Insulin stimulates glucose uptake into skeletal muscle and
adipose tissue by mobilizing intracellular vesicles containing
the glucose transporterGLUT4 to the plasmamembrane (PM)2
(reviewed in Refs. 1, 2). Integration of GLUT4 into the PM
facilitates glucose entry into the cell. Skeletal muscle accounts
for80% of insulin-dependent postprandial glucose uptake (3,
4); skeletal muscle insulin resistance contributes to the devel-
opment of type 2 diabetes (5). Hence, targeting mechanisms to
promote insulin-stimulated GLUT4 vesicle mobilization pro-
vides a means to restore insulin sensitivity.
Skeletal muscle cells respond to insulin via the presence of
insulin receptors at the cell surface, triggering the canonical
insulin signaling pathway: insulin binds to the insulin receptor
to induce autophosphorylation, which in turn induces tyrosine
phosphorylation of insulin receptor substrate and, subse-
quently, phosphorylation of PI3K (reviewed in Refs. 6, 7). In
skeletal muscle, the pathway downstream of PI3K bifurcates
into two parallel and independent arms: one arm leads to phos-
phorylation of the protein kinase B/AKT, and the second arm
leads to the activation of the monomeric small GTPase protein
Rac1 (8). Rac1 activation evokes phosphorylation of its effector
protein, p21-activated kinase-1 (PAK1) (9, 10). Although the
events downstream of the AKT armof insulin signaling are well
documented in these glucose uptake mechanisms (11–16), the
events downstream of PAK1 remain incompletely determined.
In humans, insulin-induced PAK1 activation is impaired in
skeletal muscle in acute (intralipid infusion) and chronic (high-
fat diet–induced obesity and type 2 diabetes) insulin-resistant
states, implicating the requirement of PAK1 for insulin-depen-
dent glucose uptake/disposal (9).Whole-body PAK1knock-out
mice replicate these findings (17), as did use of the group 1 PAK
inhibitor IPA3, providing evidence for PAK1 involvement in
actin remodeling to promoteGLUT4 vesicle translocation (18).
Stimulus-induced actin cytoskeletal remodeling requires the
action of multiple actin-binding proteins that coordinate spa-
tial and temporal polymerizationwith depolymerization events
(19). In a non-canonical signalingmechanism, PAK1was found
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to regulate insulin-induced actin remodeling in skeletal muscle
cells in a LIM kinase–independent manner, signaling to cofilin
(actin severing protein) to initiate actin depolymerization (18,
20). Actin remodeling in skeletal myotubes and myoblasts has
been tied to insulin-stimulated localization of GLUT4 to
plasma membrane ruffles (21–23).
In some cell types, PAK1 can regulate actin remodeling by
phosphorylating p41ARC, a regulatory subunit of the ARP2/3
complex that promotes actin polymerization (24–26). Although
ARP2/3 has been implicated as a positive factor in GLUT4
translocation in skeletal muscle cells (20), involvement of
p41ARC remains untested. PAK1 is implicated in actin poly-
merization via its ability to enhance binding of the actin nucle-
ating/polymerization factors cortactin andN-WASP (27). Cor-
tactin is an actin nucleation–promoting factor that mediates
the assembly and organization of actin cytoskeletal meshwork
(28). Cortactin is required for insulin-induced GLUT4 translo-
cation and glucose uptake in skeletal muscle cells (29). In
Hep2b clonal hepatocytes, phosphorylation of cortactin by
PAK1 specifically at Ser-405 and Ser-418 increased the affinity
of cortactin for a known enhancer of actin polymerization, neu-
ronal Wiskott-Aldrich syndrome protein (N-WASP) (27).
Overexpression of a dominant-negative N-WASP protein was
used to first implicate these factors and actin polymerization
in GLUT4 translocation (30). However, whether N-WASP is
required for insulin-induced actin remodeling or glucose
uptake in skeletalmuscle cells has not been investigated.Hence,
PAK1may signal through p41ARC3ARP2/3 or cortactin3N-
WASP or both pathways to evoke actin polymerization to sup-
port GLUT4 vesiclemobilization and glucose uptake in skeletal
muscle cells.
To explore these possible pathways, we have used chemical
inhibitors, live-cell imaging, and immunoprecipitation studies
to discern the insulin-induced changes in protein–protein
complexes concurrent with changes in glucose uptake and
GLUT4 translocation. N-WASPwas determined to be essential
as a mediator of PAK1 in insulin-induced actin remodeling and
GLUT4 translocation and to be associated with cortactin.
Further, PAK1 activation was required for its association with
p41ARC and actin in skeletal muscle cells. Altogether, these
findings elucidate new elements of the insulin signaling path-
way downstream of Rac1–PAK1 in skeletal muscle that dictate
cortical F-actin remodeling and subsequent mobilization of
GLUT4 vesicles and fusion to the cell surface.
Results
p41ARC serves as a PAK1 substrate and N-WASP binding
partner in insulin-stimulated skeletal muscle cells
In a cancer cell line, PAK1 phosphorylates the Arp2/3
subunit p41ARC (24). Testing this in L6-GLUT4myc myo-
blasts, we show that insulin stimulated the phosphorylation
of p41ARCThr-21 (Fig. 1A) and that this was decreased in lysates
from IPA3-treated cells (Fig. 1B). N-WASP co-immunopre-
cipitation studies revealed the interaction of p41ARC with
N-WASP in these same myoblast lysates; the abundance of
these complexes increased in response to insulin stimulation
(Fig. 1C). This insulin-stimulated increase in p41ARC–N-
WASP association was abolished by pretreatment of myoblasts
with the PAK inhibitor IPA3. These data implicate PAK1 as an
upstream activator of p41ARC in the insulin signaling cascade.
N-WASP is required for insulin-stimulated GLUT4 vesicle
translocation and glucose uptake
Deletion of N-WASP is lethal in vivo, and its depletion
in cultured cells ablates differentiation (31), and, hence, its
role in insulin-stimulated skeletal myotube glucose uptake
has remained undetermined. Circumventing this issue, we
employed a specific inhibitor of N-WASP, wiskostatin (WISK).
WISK is an allosteric inhibitor of N-WASP that interacts with a
cleft in the regulatoryGTPase-binding domain ofN-WASP and
stabilizes the native autoinhibited conformation (32). Myo-
tubes respondwell to insulin in glucose uptake assays, although
they have limited use in live-cell imaging–based assays or
assays requiring large amounts of protein (co-immunoprecipi-
tations). Therefore, multiple dosages of WISK were initially
tested in myoblasts to determine whether any effects on insu-
lin-induced GLUT4 translocation to the PM were apparent.
Insulin induced mobilization of GLUT4 from the intracellular
compartments to the plasma membrane of L6-GLUT4myc
myoblasts, and this was ablated by 10 M WISK (Fig. 2, A and
B). WISK also inhibited insulin-stimulated glucose uptake into
L6-GLUT4myc myotubes (Fig. 2C). WISK used acutely and at
this low concentration avoided the reported side effect of
decreasing cellular ATP levels (33); levels four times above this
dose clearly evoked ATP depletion (Fig. 2D). Cell viability was
also assessed, with the 10MWISK dosage being without effect
(Fig. 2E). These data reveal a requirement for N-WASP in insu-
lin-stimulatedGLUT4 vesicle translocation and glucose uptake
in L6 myoblasts and myotubes, respectively.
N-WASP regulates insulin-induced localized F-actin
remodeling
To determine the requirement for N-WASP signaling in the
process of F-actin remodeling in skeletal muscle cells, live-cell
imaging of L6 myoblasts harboring the LifeAct-GFP biosensor
was performed, as described previously (18). LifeAct is a 17-res-
idue peptide from the actin-binding protein Abp140 linked to
the N terminus of GFP to form LifeAct-GFP, binding specifi-
cally to F-actin in live cells without adversely affecting F-actin
dynamics (34). Insulin-stimulated changes in actin polymeriza-
tion in single cells of L6 myoblasts were captured over a period
of 10 min, showing localized actin remodeling within 5–6 min
of insulin addition inmultiple cells within the field (supplemen-
tal Movie 1; a representative cell is shown in Fig. 3A, vehicle
(Veh), arrows denote sites of remodeling). Addition of 10 M
WISK fully ablated insulin-induced actin remodeling (supple-
mental Movie 2 and Fig. 3A,WISK). WISK did not alter global
actin cytoskeletal changes because the F:G-actin ratio remained
similar compared with vehicle-treated cells (Fig. 3, B and C).
Cells from the same passages that were treated with phalloidin
(polymerizer) showed the expected F-actin content of 75%,
validating that our F:G-actin ratios fell within the dynamic
range of the assay according to the established parameters of
the manufacturer. Furthermore, insulin did not evoke global
changes to F:G-actin ratios, supporting the prevailing concept
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in the field that insulin induces localized and not global remod-
eling of actin. These data suggest that N-WASP is required
for localized insulin-stimulated actin remodeling to support
GLUT4 vesicle translocation in skeletal muscle cells.
N-WASP interaction with actin and cortactin in response to
insulin requires PAK activation
Todeterminewhether PAK1 activitymight be linked to actin
polymerization in skeletal muscle cells, vehicle- or IPA3-
treated myoblasts left unstimulated or stimulated with insulin
were used in immunoprecipitation studies. Indeed, immuno-
precipitation of N-WASP revealed a 6-fold increase in associa-
tion of actinwithN-WASP in response to insulin stimulation in
vehicle-treated L6 myoblasts (Fig. 4A); this interaction was sig-
nificantly reduced in cells treated with IPA3. The actions of
insulin and IPA3 to activate and inhibit PAK1 activation,
respectively, were validated in each independent experiment
using a phospho-specific PAK1/2 antibody. The p-PAK1/2
antibody recognized a 68-kDa band corresponding to the
molecular mass of PAK1 that increased upon insulin stimula-
tion and was suppressed by IPA3 (Fig. 4B); this was normalized
for PAK1 content to quantify the proportion of insulin-stimu-
lated PAK1 activation. A prior study showed PAK2 to be
dispensable for insulin-stimulated GLUT4 translocation in
L6-GLUT4myc myoblasts (18). Similar to WISK inhibition,
IPA3-mediated inhibition had no global effects on the F:G-ac-
tin ratio (Fig. 4C).
Insulin-stimulated GLUT4 vesicles in muscle and fat cells
traffic to the t-SNARE protein Syntaxin 4 (STX4) at the PM for
docking and fusion (35–37), and STX4 is noted for its unusual
ability to interact both directly and indirectly with F-actin (but
notwithG-actin) (38, 39).Hence,we questionedwhether PAK1
oversight of localized cortical F-actin polymerization would
impact STX4 activation at the PM. Testing this, IPA3-treated
L6 cells failed to show insulin-stimulated activation of STX4
(Fig. 4D). Being similar to that of cells treated with the actin
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Figure1.An insulin-dependent interactionofp41ARCwithN-WASP is regulatedbyPAK1.A andB, L6-GLUT4mycmyoblastswerepretreatedwith vehicle
(DMSO) or 25M IPA3 for 50min and stimulatedwith 100 nM insulin for an additional 10min. Whole-cell lysates of L6-GLUT4mycmyoblasts were analyzed for
phosphorylated (p)-p41ARCThr-21, p41-ARC, PAK1, and p-PAK1/2Thr-423/402 (the p-PAK1 band migrates at 68 kDa) levels. The means S.D. from at least three
independent sets of cell lysates are shown in the bar graph. *, p 0.05; **, p 0.01. Black vertical lines between lanes indicate splicing of lanes fromwithin the
same gel exposures. C, thewhole-cell lysates from abovewere then immunoprecipitated (IP) with N-WASP antibody, and coimmunoprecipitated p41ARCwas
determined by immunoblotting (IB). The ratio of p41ARC/Ponceau S staining of the same blot was quantified, and the means S.D. from three independent
sets of cell lysates were determined. *, p 0.05.
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depolymerizing agent Latrunculin B, these data are consistent
with the concept that a link between F-actin and STX4 may be
important for insulin-stimulated promotion of the GLUT4 dock-
ing/fusion process. Moreover, these data support the notion of
insulin-stimulated PAK1 activation fostering the association.
To interrogate the role of PAK1 in the interaction of
N-WASP and cortactin in myoblasts, cells were transfected
with pGFP–N-WASP, stimulated with or without insulin, and
the resulting cell lysateswere used in anti-GFP immunoprecipi-
tation reactions. Although the GFP–N-WASP protein was
equivalently immunoprecipitated from the different lysates (IB:
N-WASP), cortactin was co-immunoprecipitated in 2-fold
greater quantities from insulin-stimulated cells, and this
increase was attenuated in cells pretreated with IPA3 (Fig. 5A).
Cortactin levels in the L6myoblast lysateswere slightly reduced
only under the insulin-stimulated condition, although this was
not seen in primary muscle homogenates (data not shown).
Inhibition of N-WASP byWISK was without effect upon AKT
activation (Fig. 5B). Similar to the effect of IPA3 and LatB,
N-WASP inhibition diminished the insulin-stimulated activa-
tion of STX4 (Fig. 5C).
Discussion
In this study, we report the existence of new signaling ele-
ments downstream of PAK1 that regulate the localized cortical
F-actin polymerization arm of the actin remodeling process.
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Figure 2. N-WASP inhibition blunts insulin-stimulated glucose uptake and GLUT4 translocation. A, L6-GLUT4myc myoblasts were treated with vehicle
(DMSO) or 10 M WISK and stimulated with 100 nM insulin for 20 min simultaneously. Cells were fixed and left unpermeabilized for labeling with anti-myc
antibody. The immunofluorescent intensity of cell surface GLUT4was normalized to the nucleic acid staining dye Syto 60. Values aremeans S.D. from three
independent sets of cells. **, p 0.01. B, L6-GLUT4mycmyoblastswere treatedwith 0, 5, 10, 20, or 25MWISK togetherwith 100nM insulin for a total of 20min.
Cells were fixed and left unpermeabilized for labeling with anti-myc antibody. The immunofluorescent intensity of cell surface GLUT4 was normalized to the
nucleic acid staining dye Syto 60. Values are means  S.D. from three independent sets of cells. ***, p  0.001. C, L6-GLUT4myc myotubes were used for
2-deoxyglucose uptake assays. Values are means S.D. from three independent sets of cells. *, p 0.05. D and E, L6-GLUT4mycmyoblasts were treated with
DMSO orWISK, and the cellular ATP levels and percentage of viable cells were determined, respectively. Values aremeans S.D. from three independent sets
of cells. **, p 0.01; ***, p 0.001.
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We show that, upon insulin stimulation, PAK1 phosphorylates
p41ARC and regulates p41ARC interactions with N-WASP
coordinate with the associations of N-WASP with cortactin
and actin. Because all of these associationswere ablated by inac-
tivation of PAK1, it is likely that PAK1 activation is a proximal
step in the process of the formation of these actin-polymerizing
complexes. Furthermore, the requirement for N-WASP in
localized F-actin polymerization/ruffling and for GLUT4 vesi-
cle translocation and glucose uptake was demonstrated using
the N-WASP inhibitor wiskostatin. These results expand the
model of insulin-stimulated glucose uptake in skeletal muscle
cells by implicating p41ARCas a new component of the insulin-
signaling cascade and connecting PAK1 signaling to N-WASP-
cortactin–mediated actin polymerization and GLUT4 vesicle
translocation.
This is the first report of p41ARC serving as a downstream
effector of PAK1 signaling in skeletal muscle cells. PAK1 has
been shown to phosphorylate p41ARCThr-21 in vitro, in MCF-7
cancer cells upon EGF stimulation (24, 26), and in melanoma
cells (25). p41ARC is one of two principle ARP2/3 subunits, the
other and more commonly used subunit being ARPC1A (40).
However, to the best of our knowledge, there are no reports of
ARPC1A linkage to PAK1. Further supporting the concept of
p41ARC in actin polymerization and remodeling, a recent
study has demonstrated that p41ARC can be bound and stabi-
lized by cortactin and that this promotes actin assembly and the
formation of long actin tails in HeLa cells (41). This adds a new
twist to efforts to hamper cellular PAK1 signaling, efforts that
would impair a positive and necessary node in a process vital to
themaintenance of glucose homeostasis.Having now identified
p41ARC as a critical missing link between the insulin signaling
and the polymerizing aspect of F-actin remodeling in skeletal
muscle cells, future studies detailing the molecular mecha-
nisms will be important to identify ways to improve insulin-
stimulated glucose uptake in insulin-resistant muscle.
Indeed, identifying N-WASP as a p41ARC binding partner
also provides a novel aspect to the canonical insulin signaling
cascade in skeletal muscle cells. Our data concur with a prior
study implicating N-WASP in GLUT4 translocation in 3T3L1
adipocytes (30) using a dominant-negative N-WASP mutant.
WISK-mediated inhibition of N-WASP activation rapidly and
thoroughly abolished insulin-induced cortical actin remodel-
ing and decreased insulin-stimulated GLUT4 translocation in
skeletal muscle cells. WISK inhibited these events during the
insulin-stimulation period; no lengthy pre-treatment was
required to halt these signaling events, being effective at a low
dosage that neither diminished ATP levels or cell viability. This
supports the concept that the activation of N-WASP, and not
its synthesis or the synthesis of other proteins, underlies the
PAK1-mediated cascade requiring N-WASP. Furthermore,
that insulin-stimulated AKT phosphorylation remained un-
changed in the presence ofWISK implicates N-WASP in a par-
allel pathway, leading toGLUT4 vesiclemobilization in skeletal
muscle. An alternative to this would be that N-WASP acts
downstream of AKT; this has not been demonstrated to date in
any cell type to the best of our knowledge. This is consistent
with data using inhibitors of PAK1 andRac1 and the notion that
a Rac13PAK1 signaling pathway occurs independent of/in
parallel to the established AKT signaling pathway in skeletal
muscle cells.
Insulin stimulation increased the association of N-WASP
with cortactin in L6 myoblasts, and this was completely abol-
ished by IPA3, indicating a role for PAK1 in regulating this
interaction. A potential mechanism could involve PAK1 phos-
phorylation of cortactinSer-408,Ser-4118, as it does in Hep2b cells,
coincident with increased association of cortactin-N-WASP
and increased localized actin polymerization (27). However,
PAK1-mediated phosphorylation of cortactinSer-113 as seen in
smooth muscle cells inhibits cortactin–actin association and
F-actin polymerization (44). Alternatively, Rac1 may activate
N-WASP, as has been reported to occur in vitro (42), in tandem
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with PAK1 regulation of cortactin. Cortactin andN-WASP can
synergistically activate the ARP2/3 complex via cortactin bind-
ing to ARP3 and N-WASP binding to p41ARC and ARP2 (43).
Although both scenarios involve cortactin, and cortactin is
reportedly required for insulin-induced GLUT4 translocation
and glucose uptake in skeletal muscle cells (29), validation of
the role of cortactin in primary skeletal muscle will require new
antibodies; at present, the requisite antibodies are not commer-
cially available. In addition, although IPA3 and WISK are con-
sidered highly selective for their targets, it remains possible that
either drug could impact Rac1 activation via an unknown feed-
back signal; this requires testing over a thorough time course
given the cyclic nature of the remodeling process. Regarding
IPA3, our studies showed it to reduce binding of N-WASP to
p41ARC and cortactin back to basal levels, yet there remained
a small and statistically insignificant amount of residual
N-WASP-actin binding. Although PAK-independent signaling
could be responsible, IPA3 only inhibits unphosphorylated
PAK1 (45). Given that our data showed a residual level of insu-
lin-stimulated p-PAK1 in cell lysates used for the N-WASP-
actin co-immunoprecipitation, this could account for the resid-
ual insulin-stimulated N-WASP–actin binding observed.
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L6-GLUT4myc myoblasts pretreated with vehicle (DMSO) or 25 M IPA3 were stimulated with 100 nM insulin for 10 min. F- and G-actin were separated by
ultracentrifugation and analyzed on SDS-PAGE. Data represent the means  S.D. of three sets of cell F:G-actin ratios. p  0.05. D, L6-GLUT4myc myoblasts
pretreatedwith vehicle, 25M IPA3, or 10M Latrunculin B (LatB) were stimulatedwith 100 nM insulin for 5min andharvested for use in STX4 activation assays,
as described under “Experimental Procedures.” Values are the means  S.D. of three independent experiments using at least two independent batches of
recombinant GST-VAMP2 protein. **, p 0.01.
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This study contributes to the body of knowledge on actin
remodeling in skeletal muscle cells by revealing the involve-
ment of phospho-p41ARC–N-WASP–cortactin interactions.
However, this signaling cascade, overseeing the process of
localized F-actin polymerization, must be balanced with
respect to the actin depolymerization signaling cascade, involv-
ing cofilin and slingshot 1 (SSH1) (20). Indeed, the products of
depolymerization are G-actinmonomers, and thesemonomers
are the building blocks of F-actin filaments. Conceptually, it is
by compilation of these opposing arms of the actin remodeling
cycle that the spatial and temporal rearrangement of cortical
F-actin creates tracks for the GLUT4 vesicles to move along to
the cell surface STX4-based SNARE docking and fusion sites.
Future studies are warranted to visualize these events in live
skeletal muscle cells, as can currently be seen in 3T3L1 adi-
pocytes (46), and discern the detailed mechanisms regarding
the ability of insulin to orchestrate the balance favoring actin
polymerization and actin depolymerization.
Altogether, our new findings place PAK1 as a central regula-
tor of insulin sensitivity tomaintain glucose homeostasis, and a
reduction in PAK1 signaling/abundance might be a potential
risk factor for prediabetes susceptibility. Because PAK1 is such
a central “hub” for activities in actin remodeling in many cell
types, identification of the primary pathways emanating from
PAK1 in skeletal muscle will be important as a means to inter-
vene beyond any PAK1mutations or deficiencies. This will also
circumvent any issues raised by retrospective samples associat-
ing PAK1 hyperactivation with various types of cancer (47).
Hence, efforts to restore PAK1 signaling leading toGLUT4 ves-
icle exocytosis in skeletal muscle have the potential to reinstate
insulin sensitivity in prediabetic and type 2 diabetic individuals.
Experimental procedures
Materials
Rat L6 GLUT4-myc skeletal muscle cells expressing c-myc–
tagged GLUT4 protein were purchased from Kerafast and cul-
tured as described previously (48). MEM- medium was pur-
chased from Invitrogen. Porcine insulin, DMSO, WISK, and
rabbit anti-actin antibody were purchased from Sigma. The
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Figure 5. A PAK1-regulated, insulin-dependent N-WASP–cortactin interaction. A, L6-GLUT4myc myoblasts were transfected to express GFP-tagged
N-WASP and, after 48 h, pretreatedwith vehicle (DMSO) or 25M IPA3 for 50min and stimulatedwith 100nM insulin for an additional 10min.Whole-cell lysates
were immunoprecipitated (IP) with anti-GFP antibody, and coimmunoprecipitated cortactin was determined by IB. Bars represent the means S.D. of four
independent sets of L6 cells. **, p 0.01. B, AKT activation in cells treatedwith or withoutWISK, representative of three independent sets of cells. p 0.05/not
significant (NS). C, L6-GLUT4myc myoblasts treated with vehicle or 10 M WISK were stimulated with 100 nM insulin for 5 min and harvested for use in STX4
activation assays, as describedunder “Experimental Procedures.” Values are themeansS.D. of four independent experiments using at least two independent
batches of recombinant GST-VAMP2 protein. **, p 0.01.
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LifeAct-GFP plasmid was kindly provided by Dr. Louis Philip-
son (University of Chicago (49)). The recombinant GFP-tagged
N-WASP plasmid was kindly provided by Dr. Susan Gunst
(Indiana University) (50). The F:G-actin ratio kit was obtained
fromCytoskeleton (Denver, CO). IPA3, protein G beads, and
mouse anti-c-myc antibody were purchased from Santa Cruz
Biotechnology (catalog no. sc-40, Santa Cruz, CA). Rabbit
anti-phospho-PAK1Thr-423/phospho-PAK2Thr-402 (catalog no.
2601), rabbit anti-PAK1 (catalog no. 2602), rabbit anti-N-
WASP (catalog no. 4848), and rabbit anti-cortactin (catalog no.
3502) antibodies were obtained from Cell Signaling Technol-
ogy (Danvers, MA). Rabbit anti-p41ARC antibody (catalog no.
AP4321) and rabbit anti-phospho-p41ARCThr-21 (catalog no.
AP4351)were obtained fromECMBiosciences (Versailles, KY).
Rabbit polyclonal GFP antibody conjugated to Sepharose beads
was purchased from Abcam (Cambridge, MA, catalog no.
ab69314). Fetal bovine serum and goat anti-mouse horseradish
peroxidase secondary antibody were obtained from Thermo
Fisher Scientific (Rockford, IL). Goat anti-rabbit horseradish
peroxidase secondary antibody was purchased from Bio-Rad.
ECL, ECL Prime, and SuperSignalTM Femto were purchased
from GE Healthcare and Pierce, respectively.
Cell culture and viability
L6-GLUT4myc myoblasts were grown as monolayers in
MEM- medium supplemented with 10% fetal bovine serum
and 1% (v/v) antibiotic–antimycotic solution. L6-GLUT4-myc
myoblasts at 40% confluency were differentiated intomyotubes
by incubation in MEM- medium containing 2% fetal bovine
serum (51, 52). For all studies involving IPA3, L6-GLUT4-myc
myoblasts ( 90% confluency) were preincubated in serum-
freemedium for 2 h, with IPA3 added for the times indicated in
the figures just prior to insulin stimulation (100 nM). With the
exception of the live-cell imaging studies, all experiments using
WISK were preincubated in serum-free medium for 2 h, with
WISK and insulin (100 nM) added simultaneously. Cell viability
was assessed using trypan blue staining (Gibco). Cells were har-
vested in 1%Nonidet P-40 lysis buffer containing 25mMHEPES
(pH 7.4), 1% Nonidet P-40, 10% glycerol, 50 mM sodium fluo-
ride, 10 mM sodium pyrophosphate, 137 mM NaCl, 1 mM
sodium vanadate, 1 mM phenylmethylsulfonyl fluoride, 10
g/ml aprotinin, 1g/ml pepstatin, and 5g/ml leupeptin and
cleared of insoluble material by centrifugation at 13,000 g for
10 min at 4 °C. The cleared lysate was used for immunoblot
analyses.
Cell surface GLUT4myc detection
Cell surface GLUT4myc detection was performed as
described previously (53). Briefly, L6-GLUT4-myc myoblasts
were incubated in serum-free medium containing WISK (10
M) or vehicle (DMSO) for 20 min together with insulin (100
nM) at 37 °C. Cells were then fixedwith 4%paraformaldehyde in
PBS for 20min at room temperature, blocked inOdyssey block-
ing buffer (LI-COR Biosciences, Lincoln, NE) for 1 h at room
temperature, and incubated with mouse anti-Myc antibody
(1:100) overnight at 4 °C. Cells were extensively washed with
PBS and then incubated with infrared-conjugated secondary
antibody for 1 h at room temperature. The immunofluores-
cence intensity of the IR-conjugated secondary antibody was
quantified using the Odyssey CLx infrared imaging system (LI-
COR Biosciences), and data were normalized to Syto 60 (Invit-
rogen), a red fluorescent nucleic acid stain.
2-deoxyglucose uptake assay
The 2-deoxyglucose uptake assay was performed as de-
scribed previously (54). Briefly, L6-GLUT4myc myotubes
were preincubated in serum-free FCB buffer (125 mM NaCl, 5
mM KCl, 1.8 mM CaCl2, 2.6 mM MgSO4, 25 mM HEPES, 2 mM
pyruvate, and 2% BSA) for 30 min, and WISK or vehicle was
added with insulin for a total period of 20 min. Glucose uptake
was initiated by addition of 2-deoxy[1,2,-3H]glucose (0.055
Ci/l), and uptake was terminated after 5 min by four quick
washes with ice-cold PBS followed by addition of 250 l of 1 N
NaOH for quantitation of [3H] using liquid scintillation. Data
were normalized for variability in protein concentration, as
determined by Bradford assay.
Cellular ATP levels
L6-GLUT4myc myoblasts were incubated with serum-free
medium for 2 h and treated with DMSO (vehicle) or different
concentrations of wiskostatin for a total of 20 min. The ATP
concentration from these cells was determined by following the
manufacturers protocol (ATPlite luminescence assay system,
PerkinElmer Life Sciences, 6016943) and using a SynergyTM
HTX multimode microplate reader (BioTek).
Immunoblotting
Proteins in cell lysates were resolved using 10% SDS-PAGE
and transferred to PVDF or nitrocellulose membranes for
immunoblotting. Immunoreactive bands were visualized using
ECL or ECL Prime reagents and imaged using a Chemi-Doc
Touch gel documentation system (Bio-Rad).
Live-cell imaging
L6-GLUT4mycmyoblastswere seeded onMatTek glass-bot-
tom culture dishes at a density of 300,000 cells/35-mm dish. At
40% confluency, cells were transfected with the LifeAct-GFP
plasmid using Effectene transfection reagent (Qiagen, Valencia,
CA). Live-cell imaging was performed on cells 48 h post-trans-
fection. Briefly, on the day of the experiment, the cells were
preincubated in serum-free KRPH buffer (120 mM NaCl, 2.5
mMKCl, 20mMHEPES, 1.2 mMMgSO4, 1mMNaH2PO4, and 2
mMCaCl2) supplementedwith 5mMD-glucose for 3 h, and then
DMSO or WISK was added 10 min before addition of 100 nM
insulin for live-cell imaging. LifeAct-GFP imaging was per-
formed on a Keyence imaging system outfitted with a 63
objective and a sample chamber with controlled temperature,
humidity, and CO2. Images were captured every 60 s starting 1
min before addition of insulin and continued until 10 min after
the addition of insulin. Representative cells from each treat-
ment group were selected from the real-time movies (supple-
mental Movies 1 and 2).
Immunoprecipitation
L6-GLUT4myc myoblasts transfected to overexpress GFP–
N-WASP protein were incubated in serum-free medium for
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2 h, pretreated with IPA3 for 50 min, and stimulated with 100
nM insulin for 10 min. Whole-cell lysate (2.5 mg protein) was
immunoprecipitated by incubation with 40 l of rabbit poly-
clonal GFP antibody conjugated to Sepharose beads (Abcam,
catalog no. ab69314) overnight. Non-transfected cell co-immu-
noprecipitation reactions were conducted similarly using rab-
bit anti-N-WASP antibody (catalog no. 4848, Cell Signaling
Technology), followed by incubationwith proteinG beads for
2 h at 4 °C. Immunoprecipitated proteins were washed three
times with lysis buffer and eluted with SDS sampling buffer
containingDTT. Eluted proteins were resolved using 10% SDS-
PAGE and transferred to PVDF or nitrocellulose membranes
for immunoblotting. N-WASP immunoblotting or Ponceau S
staining was used to evaluate protein loading.
F:G-actin ratio in L6-GLUT4mycmyoblasts
L6-GLUT4myc myoblasts were incubated with serum-free
medium for 2 h and treated with DMSO or 10 M WISK with
100nM insulin for a total of 20min. The F:G-actin ratio from the
treated cells described above was determined by following the
manufacturers protocol (Cytoskeleton).
STX4 activation assay
The GST-VAMP2 protein was generated in Escherichia coli
and purified by glutathione–agarose affinity chromatography
for use in the STX4 accessibility assay. L6 cell lysates were pre-
pared from cells stimulated with insulin with or without IPA3,
LatB, or WISK treatment. GST-VAMP2 protein linked to Sep-
harose beads was combined with 2 mg of each type of L6 myo-
blast detergent cell lysate for 2 h at 4 °C in 1%Nonidet P-40 lysis
buffer, followed by three stringent washes with the lysis buffer.
The associated proteins were resolved on 10% SDS-PAGE, fol-
lowed by their transfer to PVDF membranes for immunoblot-
ting for STX4, as described previously (55).
Statistical analysis
All data were expressed as the mean  S.D. and assessed by
Student’s t test (only Fig. 1,A and B) and analysis of variance with
a Tukey post-hoc test using GraphPad PrismTM (La Jolla, CA).
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